1999
DOI: 10.1248/cpb.47.928
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Structure-Activity Relationship of a New Series of Potent Angiotensin II Receptor Antagonists: Pyrazolo(1,5-a)pyrimidine Derivatives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…Similarly, replacing the arylmethyl amines with the corresponding ether analogue 22 was not tolerated. Replacement of the 2-pyridyl moiety with other heterocyclic systems such as imidazoles (24 and 25), methylpyridinyl (26), furan (27), thiophene (28), thiazole (29) and quinoline (30) generally resulted in a lack of antimycobacterial activity at the highest concentration tested (MIC 99 > 160 µM). The exception was the methylimidazole analogue 23, which displayed good (MIC 99 = 5 µM) activity.…”
Section: Modifications To the 7-positionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, replacing the arylmethyl amines with the corresponding ether analogue 22 was not tolerated. Replacement of the 2-pyridyl moiety with other heterocyclic systems such as imidazoles (24 and 25), methylpyridinyl (26), furan (27), thiophene (28), thiazole (29) and quinoline (30) generally resulted in a lack of antimycobacterial activity at the highest concentration tested (MIC 99 > 160 µM). The exception was the methylimidazole analogue 23, which displayed good (MIC 99 = 5 µM) activity.…”
Section: Modifications To the 7-positionmentioning
confidence: 99%
“…Pyrazolo [1,5-a]pyrimidines are of chemical and pharmacological importance as purine analogues, and derivatives have been applied in various therapeutic areas such as antitumor, [15][16][17][18][19] antidepressant, [20][21] antibacterial, 22 antiviral, 23 antidiabetic 24 and antihypertensive agents. 25,26 Representatives of the SFK29 series (1-6, Figure 1) were selected for resynthesis based on their activities (MIC 99 < 5 µM) and confirmatory testing Based on its structural novelty, broad activity, and acceptable potencies, the aminopyrazolo[1,5-a]pyrimidine series was selected for a medicinal chemistry optimisation campaign. Herein, we present the synthesis, structure activity relationship (SAR), and in vitro Absorption, Distribution, Metabolism, Excretion (ADME) studies.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, reaction of aminopyrazole 5 with ethyl acetoacetate 16a and ethyl 2‐methyl‐3‐oxobutanoate 16b afforded two possible isomeric products 17 and 18 . Structure 18 was excluded on the basis of spectral data and analogy with previous work . The formation of 17 is assumed to proceed through the condensation of the oxocyclic amino group in 5 with the carbonyl of acetyl moiety followed by in situ heterocyclization through elimination of ethanol (Scheme ).…”
Section: Resultsmentioning
confidence: 99%
“…The structural activity studies showed the methyl substituent at the 3-position to be essential for potent in vitro activity. We present the design syntheses and biological data of a series of pyrazolo (1,5a) pyrimidine derivatives, which are orally active, receptor antagonists [12].…”
Section: Angiotensin Receptor Antagonistsmentioning
confidence: 99%